North America Aspergillosis Treatment Market Size & Outlook
North America aspergillosis treatment market, 2018-2030 (US$M)
Related Markets
North America aspergillosis treatment market highlights
- An overview of the North America aspergillosis treatment market trends heading towards 2030. The North America market generated a revenue of USD 1,751.5 million in 2022.
- The overall growth of the North America market from 2022 to 2030. The market is expected to grow at a CAGR of 3.1% from 2023 to 2030.
- A look at the North America market revenues per segment in 2022. In terms of segment, allergic aspergillosis was the largest revenue generating type in 2022.
- The segment witnessing the fastest revenue growth within the market. Chronic Aspergillosis is the most lucrative type segment registering the fastest growth during the forecast period.
- An overview of North America market per country. Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 1,751.5 million |
| Market revenue in 2030 | USD 2,241.8 million |
| Growth rate | 3.1% (CAGR from 2022 to 2030) |
| Largest segment | Allergic aspergillosis |
| Fastest growing segment | Chronic Aspergillosis |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allergic Aspergillosis, Chronic Aspergillosis, Invasive Aspergillosis |
| Key market players worldwide | Pfizer Inc, Merck & Co Inc, Novartis AG ADR, Astellas Pharma Inc, Bayer AG, Mayne Pharma Group Ltd, Pulmatrix Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 41.2% of the global aspergillosis treatment market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,405.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aspergillosis Treatment Market Scope
Aspergillosis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America aspergillosis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aspergillosis treatment market will help companies and investors design strategic landscapes.
Allergic aspergillosis was the largest segment with a revenue share of 49.07% in 2022. Horizon Databook has segmented the North America aspergillosis treatment market based on allergic aspergillosis, chronic aspergillosis, invasive aspergillosis covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America aspergillosis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America aspergillosis treatment market databook
-
Our clientele includes a mix of aspergillosis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America aspergillosis treatment market, including forecasts for subscribers. This continent databook contains high-level insights into North America aspergillosis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America aspergillosis treatment market report size, by country, 2018-2030 (US$M)
North America Aspergillosis Treatment Market Share, 2022 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
